Phase 1 Study of WBRT or PCSI With REYOBIQ for Leptomeningeal Metastases
NCT07674693
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
29
Enrollment
OTHER
Sponsor class
Conditions
Leptomeningeal Metastases
Interventions
DRUG:
186RNL
Sponsor
NYU Langone Health